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The interaction of bacterial pathogens with mammalian hosts leads to a variety of
physiological responses of the interacting partners aimed at an adaptation to the new
situation. These responses include multiple metabolic changes in the affected host cells
which are most obvious when the pathogen replicates within host cells as in case
of intracellular bacterial pathogens. While the pathogen tries to deprive nutrients from
the host cell, the host cell in return takes various metabolic countermeasures against
the nutrient theft. During this conflicting interaction, the pathogen triggers metabolic
host cell responses by means of common cell envelope components and specific
virulence-associated factors. These host reactions generally promote replication of the
pathogen. There is growing evidence that pathogen-specific factors may interfere in
different ways with the complex regulatory network that controls the carbon and nitrogen
metabolism of mammalian cells. The host cell defense answers include general metabolic
reactions, like the generation of oxygen- and/or nitrogen-reactive species, and more
specific measures aimed to prevent access to essential nutrients for the respective
pathogen. Accurate results on metabolic host cell responses are often hampered by the
use of cancer cell lines that already exhibit various de-regulated reactions in the primary
carbon metabolism. Hence, there is an urgent need for cellular models that more closely
reflect the in vivo infection conditions. The exact knowledge of the metabolic host cell
responses may provide new interesting concepts for antibacterial therapies.
Keywords: metabolism of mammalian cells, regulation of metabolic pathways, cancer cells, intracellular bacteria,
common (“core”) and specific metabolic host responses, virulence-associated factors, antibacterial therapy
INTRODUCTION
Interactions between eukaryotic organisms and prokaryotes are
ubiquitous. These encounters may affect the metabolism of
the interacting partners in different ways, resulting in benefi-
cial, neutral, or detrimental outcome for the partners. Highly
stable metabolic win-win adaptations are manifested in the
endosymbiotic interactions taking place between many inver-
tebrates (especially protists and insects) and different bacteria
(reviewed by Chaston and Goodrich-Blair, 2010). Long-lasting
beneficial (or at least neutral) metabolic adaptations also occur
between mammalians and their different microbiota, e.g., the
microbiota of the gastrointestinal tract. However, these lat-
ter beneficial adaptations are less stable than the former ones
and are often disturbed by external factors, for example by
infections with bacterial pathogens (Lupp et al., 2007; Stecher
et al., 2007). Metabolic adaptations occurring in eukaryotic
hosts upon acute infection by bacterial pathogens are ulti-
mately always conflicting, as the host tries to eliminate the
invading pathogen while the pathogen tries to profit from
host nutrients and other metabolites to satisfy its bioener-
getic and biosynthetic requirements thereby damaging the host.
Frequent metabolic changes may therefore occur on the part
of the pathogen and on the part of the host in the course
of an infection. The elucidation of metabolic host responses
to bacterial infections—the topic of this review—is of great
importance for the understanding of bacterial pathogenesis.
Our present knowledge on this aspect is, however, still rather
fragmentary.
Many studies have been carried out in the past to elucidate the
responses of different hosts to bacterial infections mainly by tran-
scriptomic and proteomic approaches. The main focus of most
of these investigations has been placed on the pathogen-triggered
immune responses, inflammation processes, endosomal vesicle
formation, and trafficking (especially for intracellular pathogens),
host cell survival, apoptosis, and autophagy (for reviews, see for
example: Manger and Relman, 2000; Jenner and Young, 2005;
Tran Van Nhieu and Arbibe, 2009), while the impact of the bac-
terial infections on the metabolism of the affected hosts has been
rather set aside.
Yet, most of the more extensively studied cell responses,
in particular cell transformation, inflammation, and specific
immune response, are linked to carbon, nitrogen, and/or energy
metabolism by shared enzymes, signaling pathways, and/or tran-
scriptional regulators (Hsu and Sabatini, 2008; Mathis and
Shoelson, 2011; Andersen and Kornbluth, 2013; O’Neill and
Hardie, 2013).
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To a considerable extent, the missing in-depth knowledge
of metabolic host responses to bacterial infections is due to
the fact that the elucidation of the metabolic changes in the
host and the bacterial pathogen during infections poses major
experimental challenges in terms of the infection models and
the analytical methods (discussed in some detail in the text
below). Metabolism is a complex phenomenon that comprises
multiple steps from gene to mRNA to the active enzyme. In
general, message levels cannot be equated with enzyme pro-
tein levels nor can enzyme protein levels be equated with
enzyme activity as documented in many instances. Metabolic
flux is—as elaborated especially by Westerhoff and colleagues
(e.g., van Eunen et al., 2011)—subject to “hierarchical regu-
lation” involving changes in enzyme levels, and to “metabolic
regulation” including modulations of the activity of pre-existing
enzymes.
At present, analysis of metabolic host responses to bacterial
pathogens is probably best accessible for the interactions between
mammalian cells and intracellular bacterial pathogens, since the
infected host cell represents a fairly well-defined metabolic entity.
Intracellular bacterial pathogens may in principle interfere
with host metabolism by means of their common cell enve-
lope structures [especially peptidoglycans (PG), lipopolysaccha-
rides (LPS), lipoteichoic acids (LTA), respectively] and specific
virulence-associated factors. This interference may occur on all
levels, i.e., regulation and expression of nutrient sensors and
transporters or regulators involved in the expression of key
enzymes essential for catabolism, anabolism, and energy supply
as well as in the modulation of activity of these enzymes (for a
schematic overview, see Figure 1).
The mammalian hosts (mainly discussed here) possess a vari-
ety of differentiated cells with different overall metabolic activ-
ity and differently regulated metabolic pathways. The metabolic
activity of these “normal” cells is often low but can be activated
by various external stimuli, including microbial components
(O’Neill and Hardie, 2013). This is in contrast to most cancer
cells (often used as model host cells for the study of intracel-
lular bacteria). In these cells some catabolic and anabolic path-
ways are always highly up-regulated, while aerobic respiration
is strongly reduced even in the presence of oxygen, a metabolic
state termed “Warburg-effect” or “aerobic glycolysis” (Hsu and
Sabatini, 2008). Metabolic responses to intracellular bacteria may
therefore vary considerably depending on the infected host cell
type.
Recently, we reviewed the metabolic adaptations of some
important (mainly intracellular) human pathogenic bacteria dur-
ing intracellular growth (Eisenreich et al., 2010; Fuchs et al.,
2012). In the current review, we will focus on the metabolic
responses of the host cells to these intracellular bacterial
pathogens. For a better understanding of the complex problem,
we present in the first part of this review a condensed overview
on the major metabolic pathways, nutrient transporters, recep-
tors and regulators controlling the metabolism in mammalian
cells (for more details of this aspect, see also Supplementary
Material S1–S6), as these metabolic cell processes are poten-
tial host cell targets for the interaction with components of the
bacterial pathogens.
In the second part, we discuss common and pathogen-specific
changes in the host metabolism that are triggered by bacterial
pathogens. The focus will be on studies with human and mam-
malian model hosts or host cells, but insights deriving from
alternative infection models (e.g., Dictyostelium discoideum) will
be included when relevant metabolic data are available.
The interference especially of intracellular bacteria with the
phosphoinositide metabolism of host cells which plays a pivotal
role in the regulation of receptor-mediated signal transduction,
actin remodeling andmembrane dynamics of eukaryotic cells will
not be included in this review as this topic has been extensively
reviewed in the past (Pizarro-Cerdá and Cossart, 2004; Hilbi,
2006; Weber et al., 2009).
MAJORMETABOLIC PATHWAYS AND NUTRIENT
TRANSPORTERS OF MAMMALIAN CELLS
CATABOLIC, ANABOLIC, AND ANAPLEROTIC PATHWAYS
Glucose and glutamine are the major carbon and/or nitrogen
sources for mammalian cells (for reviews, see e.g., Wise et al.,
2008; Levine and Puzio-Kuter, 2010). In addition, other carbohy-
drates and amino acids as well as fatty acids can serve as efficient
carbon and/or energy sources. Oxidative degradation of these
nutrients occurs via the conserved catabolic pathways [glycolysis
(GL), pentose-phosphate pathway (PPP), and the tricarboxylate
cycle (TCA)], which are compartmentalized in part to the cytosol
and in part to the mitochondria (Figure 2; for more details, see
Supplementary Material S1).
Most of the low molecular nutrients, i.e., monomeric carbo-
hydrates, amino acids, fatty acids, and nucleotides, needed for
the biosynthesis of proteins, polysaccharides, lipids, and nucleic
acids, respectively, are imported from the environment by a large
number of membrane-bound transporters (see below). However,
if necessary, these cells are also capable of synthesizing the
(so-called non-essential) amino acids, fatty acids, purine and
pyrimidine nucleotides as well as porphyrines via well-known,
highly conserved anabolic pathways. Glucose and other carbo-
hydrates can be synthesized by gluconeogenesis (GN), when
nutrition is supported by alternative carbon sources, like gluco-
genic amino acids, lactate, and glycerol. The essential reactions
for GN [from pyruvate via oxaloacetate (OXA) to glucose],
are—in addition to the reversible enzymatic GL steps—the reac-
tions catalyzed by pyruvate carboxylase (PC), phosphoenolpyu-
vate (PEP) carboxykinase (PCK), fructose-1,6-bisphosphatase
(FBP), and glucose-6-phosphatase (GP) leading to OXA,
PEP, fructose-6-phosphate (F6P), and glucose, respectively
(Figure 2).
In contrast to these anabolic pathways, which can occur in
most cells, those leading to hormones and bile acids are spe-
cific for vertebrates. Synthesis of steroid hormones and bile acids
branches-off from the common steroid (cholesterol) biosynthe-
sis pathway, while synthesis of eicosanoid hormones branches-
off from the arachidonic acid pathway. The biosynthesis of
these compounds requires several cytochrome P450-dependent
hydroxylation steps, and the involvement of numerous mem-
bers of the cytochrome P450 family (encoded by the CYP genes).
Both classes of hormones participate also—among others—in the
regulation of metabolism.
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FIGURE 1 | Model showing possible interactions of common bacterial
surface components and pathogen-specific virulence factors with the
host cell metabolism in the cytosol (blue lines) and in the mitochondria
(orange). The schematic view of the host cell (gray box) metabolism
comprises glucose uptake (blue star), glycolysis (GL), pentose-phosphate
shunt (PP), tricarboxylic acid cycle (TCA), glutaminolysis (GLNLY), β-oxidation
of fatty acids (β-ox), and the electron transport chain (ETC) essential for
aerobic respiration. (A) Interaction with non-pathogenic bacteria (green
sphere) which may trigger common metabolic host cell responses (green
dashed arrows; see text for definition) mainly via cell envelope structures
(e.g., PG, LPS, LTA—green triangles). (B) Extracellular bacterial pathogens
(red sphere) may trigger in addition to these common responses (green
dashed arrows), specific metabolic host cell responses via cell-bound or
secreted virulence factors (red triangles and red circles), as well as via
specific secretion systems (e.g., T3SS or T4SS; purple boxes) translocated
effector proteins (purple circles). (C) Intracellular bacterial pathogens
replicating in membrane-surrounded vacuoles within the host cell could
trigger metabolic host responses via translocated effector proteins (purple
circles). (D) Intracellular bacterial pathogens replicating in the host cell’s
cytosol could trigger metabolic host responses via secreted or cell-bound
virulence factors (red triangles and circles). For abbreviations and further
details, see text.
Withdrawal of the TCA intermediates for biosynthetic pur-
poses may lead to the breakdown of the TCA cycle, unless the
cycle is replenished in particular by the end products of amino
acid catabolic pathways or by specific refilling (“anaplerotic”)
reactions (see also Supplementary Material S2).
Glutaminolysis (Figure 2) is an important anaplerotic pathway
for refilling the TCA cycle, especially in many cancer cells (Wise
et al., 2008). Another major anaplerotic reaction is the genera-
tion of OXA catalyzed by the mitochondrial ATP-dependent PC
that may be especially relevant during suppression of glutamine
metabolism (Cheng et al., 2011).
NUTRIENT TRANSPORTERS AND NUTRIENT SENSORS
Most nutrients are channeled into eukayotic cells by solute
carrier (SLC) transporters. The human solute-carrier gene (SLC)
superfamily comprises a large number (at least 362) of puta-
tively functional, protein-coding genes that can be divided into
55 gene subfamilies encoding membrane-bound transporters.
They represent passive transporters, symporters, and antiporters,
located in all cellular and organelle membranes (possibly except
the nuclear membrane). Transported substrates include glucose
and other sugars, amino acids and oligopeptides, nucleosides,
acetyl coenzyme A, vitamins, fatty acids and lipids, essential
metal ions, and other inorganic cations or anions. SLC trans-
porters for the major nutrients may be targets for bacterial
pathogens (Lee et al., 2009). Transporter-like sensors (“tran-
sceptors”) may be linked to general signaling pathways, such
as the protein kinase A (PKA) pathway (Hyde et al., 2003;
Holsbeeks et al., 2004). For further details on the elaborate
topic of nutrient transporters and nutrient sensors, the reader is
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FIGURE 2 | Major catabolic and anabolic pathways in mammalian cells.
Glucose uptake by the transporters GLUT or SGLT, glycolysis (GL, red arrows)
and gluconeogenesis (GN; specific reactions marked by blue arrows);
pentose-phosphate pathway (PPP; broken red arrows); tricarboxylic acid cycle
(TCA; green circle); glutaminolysis (GLNLY, magenta arrows) and the
associated TCA reactions. β-oxidation (β-Ox) and other catabolic reactions
occurring in the mitochondrium and (mainly) in the cytosol are marked by
black arrows. Anabolic reactions leading to amino acids, nucleotides, and
lipids are indicated by broken thick black arrows. Also indicated are the
reactions leading to NADH, NADPH, NAD, and ATP, respectively. Metabolites
are marked in black and enzymes in blue. Abbreviations: HK, hexokinase;
PFK, phosphofructokinase; FBP, fructose bisphosphatase; PK, pyruvate
kinase; PDH, pyruvate dehydrogenase complex; PYC, pyruvate carboxylase;
PCK, PEP-carboxylase; LDH, lactate dehydrogenase; CS, citrate synthase;
ICD, isocitrate dehydrogenase; ACL, ATP-dependent citrate lyase; ME, malate
enzyme; ETC, electron transfer chain for aerobic respiration (small red circle),
consisting of complexes I–IV and of ATPase (complex V); small blue box:
glutamine transporters SLC1A5 and ASCT2.
referred to SupplementaryMaterial S3, S4 and the specific reviews
cited there.
METABOLIC REACTIONS GENERATING ANTIMICROBIAL AGENTS (ROS
AND RNI) AND REACTIONS BALANCING THE CELL-TOXIC EFFECTS OF
THESE AGENTS
Mammalian cells [especially professional phagocytes, i.e., mono-
cytes, macrophages, neutrophils, and dendritic cells (DC)] defend
themselves against microbial infections not only by specific
immune processes, but also by different metabolic reactions as
part of the innate immunity. These reactions, mainly catalyzed by
the phagocytic NADPH oxidase (PHOX) and the inducible nitric
oxide synthase (iNOS or NOS2), respectively, generate reactive
oxygen species (ROS) and reactive nitrogen intermediates (RNI),
respectively (Bogdan et al., 2000; Nathan and Shiloh, 2000). More
details on these enzymes and the regulation of their activity are
provided in the Supplementary Material S5.
THE ROLE OF AUTOPHAGY IN METABOLISM
Autophagy is a highly conserved and tightly regulated catabolic
process which provides basic metabolites and maintains
metabolic homeostasis in cells by degrading long-lived or
damaged proteins and organelles (Klionsky, 2007; Rabinowitz
and White, 2010). Autophagy is induced by a variety of extra-
and intracellular stress stimuli, including nutrient starvation.
This dynamic process includes membrane formation and fusion,
leading to autophagosome formation, autophagosome-lysosome
fusion, and subsequently to breakdown of the autophagosomal
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contents (which contains many cytoplasmic components) by
lysosomal hydrolases. Thus, autophagy is in principle a protective
mechanism that sustains cell survival under adverse conditions.
Besides maintaining nutrient homeostasis, it is important as
defense against intracellular pathogens.
REGULATION OF METABOLIC REACTIONS IN MAMMALIAN
CELLS
Uptake and metabolism of carbohydrates (especially glucose),
fatty acids, and amino acids (especially glutamine) are controlled
by external signals, including hormonal and growth factors [e.g.,
insulin, glucagon, insulin-like growth factor (IGF), epidermal
growth factor (EGF)], external nutrients (e.g., amino acids),
and by numerous transcriptional factors (Figure 3). Interestingly,
many of the latter factors have been first recognized as tumor
suppressors or oncogenes and, hence, their role in cell cycle con-
trol, apoptosis, mitochondrial functions, etc., has been extensively
studied in the past (but is not discussed here).
In the presence of external glucose, its uptake and flux through
the initial reactions of GL are stimulated by the PI3K/AKT path-
way. Mitogens and growth factors bind to the growth factor
receptors, activate the associated tyrosine kinase which subse-
quently activates phosphoinositide 3 (PIP3)-kinase (PI3K). PI3K
activates protein kinase B (AKT) (Mosca et al., 2011). In par-
ticular, PI3K/AKT stimulates expression of the glucose trans-
porter 1 (GLUT1), hexokinase (HK-1), and phosphofructokinase
(PFK-1). PI3K/AKT inhibits fatty acid β-oxidation (β-Ox). PI3K
also activates the protooncogene c-Myc (MYC) (Dang, 2010)
which stimulates glucose uptake, but inhibits flux through the
late steps of GL. This provides early glycolytic intermediates for
FIGURE 3 | Regulation of central metabolic pathways by signaling
pathways, proto-oncogenes, and tumor suppressors. The figure provides
a rough overview how the major metabolic pathways (GL, PPP, TCA,
glutaminolysis, β-oxidation, etc.) are regulated by signaling pathways,
protooncogenes, and tumor suppressors, including mainly PI3K/AKT,
LKB1/AMPK, HIF-1, mTORC1, MYC, p53, and the p53-controlled regulators
TIGAR and PTEN. Interactions between these major players are mediated in
part by additional regulatory factors not listed in the figure (Gordan et al.,
2007; Levine and Puzio-Kuter, 2010). Red-boxed regulators repress specific
metabolic target reactions (indicated by the red bars) whereas green boxed
regulators activate specific reactions (indicated by the green arrows).
Inhibition and activation of the indicated enzymes may occur on the
transcriptional, translational of post-translational level (see text and
Supplementary Material S6 for further details). Black arrows indicate the
most relevant metabolic steps. Targeted enzymes are yellow-boxed. For
abbreviations, see Figure 2 and text.
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anabolic pathways and supports NADPH production. In addi-
tion, activated MYC drives glutamine metabolism. The tumor
suppressor p53 (Cheung and Vousden, 2010) inhibits glucose
uptake and GL (see below). However, activated AKT phospho-
rylates Mdm2, the key regulator of p53 stability. Activated Mdm2
ubiquitinates p53 which promotes p53 degradation and thereby
stimulates GL. Furthermore, the activated PI3K/AKT pathway
enhances translation of the HIF-1α subunit of the hypoxia
inducible transcription factor 1 (HIF-1) (Hellwig-Bürgel et al.,
2005). This transcription factor also stimulates expression of
genes encoding glucose transporters (especially GLUT1), several
glycolytic enzymes and lactate dehydrogenase (LDH-A).
On the other hand, signaling through the serine-threonine
liver kinase1/AMP-activated protein kinase (LKB1/AMPK)
(Shackelford and Shaw, 2009; Hardie, 2011) decreases metabolic
flux through GL in response to cell stress. Under low cellular
energy conditions (high AMP/ATP ratio), AMPK triggers GL if
sufficient external glucose is provided. This results in decreased
AMP and glucose levels. Under low glucose condition, sustained
activity of AMPK activates p53 which intervenes at several
points in GL and oxidative phosphorylation and, in general,
slows down GL and promotes oxidative phosphorylation. GL is
inhibited by p53-induced repression of the genes for GLUT1,
GLUT4, and phosphoglycerate mutase (PGM), while oxidative
phosphorylation is enhanced by the increased expression of
cytochrome oxidase 2 (SCO2). P53 also induces expression
of the “TP53-induced GL and apoptosis regulator” (TIGAR)
(Bensaad et al., 2006) and of the “tumor suppressor phosphatase
and tensin homolog deleted on chromosome 10” (PTEN) (Liu
and Feng, 2012). TIGAR inhibits the glycolytic flux by lowering
the fructose-2,6-bisphosphate levels and inhibits expression
of the glucose transporters GLUT1 and GLUT4. PTEN blocks
PI3K/AKT signaling by dephosphorylation of PIP3. P53 further
up-regulates transcription of the SESN gene and the produced
sestrin proteins stimulate AMPK, eliciting a positive feedback
loop. Another p53-activated metabolic target gene is GLS2 which
encodes glutaminase 2. This enzyme converts glutamine to
glutamate which may enhance the rate of the TCA pathway and
oxidative phosphorylation.
AMPK, p53, and AKT converge directly or indirectly on the
mammalian target of rapamycin complex 1 (mTORC1) (Dunlop
and Tee, 2009). Activated AKT suppresses the tuberous sclero-
sis complex 2 (TSC2), an inhibitor of mTORC1, thus leading to
cell growth while low AKT levels repress growth. On the other
hand, activated AMPK stimulates TSC2 leading to inhibition of
mTORC1 and hence to reduced cell growth. Figure 3 provides a
rough overview of the discussed major players of this complex
regulatory network and their metabolic targets.
Translational control elements, e.g., microRNAs (miRNAs),
also participate in the regulatory network (Turner, 2000; Klip,
2009; Gao et al., 2009; Vousden and Ryan, 2009; Glatz et al.,
2010; Liu et al., 2012; Chen et al., 2012). In addition, metabolic
fluxes and regulation of nutrient homeostasis (especially glu-
cose and amino acids) are controlled by post-translational
modifications of metabolic enzymes and regulators (mainly by
phosphorylation and acetylation) (Xiong and Guan, 2012) and
by sharing of metabolic intermediates. Autophagy may also
play an important role in regulation of nutrient homeosta-
sis under nutrient starvation conditions by providing essential
products for the metabolism. For more details on the regula-
tion of the mammalian cell metabolism, see also Supplementary
Material S6.
METHODOLOGICAL PROBLEMS RELATED TO THE ANALYSIS
OF METABOLIC HOST CELL RESPONSES TRIGGERED BY
BACTERIAL PATHOGENS
The significance of infections by bacterial pathogens on the
metabolism of the infected host was early recognized (Beisel,
1975, 1984; Richards, 1980). However, conclusions regarding
defined changes within the metabolic network of the infected
host can hardly be drawn from these studies. The introduction
of the high throughput techniques (“omics”) and other mod-
ern physical methods made the metabolic aspect of bacterial
pathogenesis better accessible. However, as already mentioned
above, most of the numerous transcriptome studies on host
responses to bacterial infections (for reviews, see Boldrick et al.,
2002; Nau et al., 2002; Jenner and Young, 2005; Tam et al.,
2008) provide only little information on metabolic changes trig-
gered by the bacterial pathogens in the infected hosts or host
cells. In addition, such changes depend to a large extent on
post-transcriptional mechanisms, i.e., turnover processes, mod-
ulations of enzymatic activities and signaling pathways (e.g.,
by phosphorylation/dephosphorylation), which are hardly rec-
ognized by conventional transcriptome analyses. Application of
proteomics for the analysis of metabolic host (cell) responses to
bacterial infections—probably better suited for detecting such
changes—is still relatively rare. More recently, metabolomics ana-
lyzing qualitatively and quantitatively small metabolites in cells
or tissue samples of the infected host by MS or NMR have been
also applied to determine changes in the metabolite patterns
(Han et al., 2008; de Carvalho et al., 2010; Antunes et al., 2011).
Other techniques which may provide valuable information on
the dynamics of metabolic changes in infected host cells include
13C-isotopologue profiling, Raman spectroscopy, nano SIMS, and
fluorescence lifetime imaging (FLIM) (Wagner, 2009; Szaszák
et al., 2011; Gillmaier et al., 2012; Musat et al., 2012). Each of
these methods has, however, specific drawbacks and only the inte-
gration of these techniques may provide a satisfactory solution to
this complex problem (Zhang et al., 2010).
Another challenging problem is the choice of “host cells”
and “animal models” used in such studies. Many investigations
of host cell responses apply established mammalian cell lines,
deriving from neoplastic (or artificially transformed) epithelial,
fibroblastic, endothelial, or hematopoietic cells. Most differenti-
ated cells perform in the non-activated state a balanced carbon
flux through GL, PPP, and the TCA cycle, and oxidative phos-
phorylation is the main route to generate ATP (Figure 4A). In
contrast, most cancer cells use—even in the presence of oxygen—
the glycolytic pathway for ATP production, a process known as
“aerobic glycolysis” or “Warburg effect” (Warburg, 1956). The
initial part of the TCA cycle and oxidative phosphorylation are
repressed in these cells. The enhanced GL is accompanied by an
increase of glucose uptake and production of metabolic inter-
mediates, needed for increased biomass (nucleic acids, lipids,
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FIGURE 4 | Major metabolic pathways in normal differentiated cells and
cancer cells. In normal differentiated mammalian cells (A), e.g., epithelial cell
or non-activated macrophages, glucose uptake, glycolysis, TCA cycle, and
aerobic respiration (indicated by the thick red arrows) are active at low
balanced levels. All other less- or non-active catabolic and anabolic pathways
are indicated by thin black and broken black arrows, respectively. In
mammalian cancer cells (B), carbon metabolism is characterized by
(Continued)
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FIGURE 4 | Continued
enhanced glucose uptake, glycolysis, pentose-phosphate shunt,
enhanced conversion of pyruvate to lactate (indicated by the thick red
arrows) and reduced conversion to acetyl-CoA by pyruvate
dehydrogenase, reduced TCA cycle, gluconeogenesis, and aerobic
respiration (indicated by the thin red and black arrows). In some
cancer cells, glutaminolysis is also highly induced with the subsequent
reactions leading to α-ketoglutarate (α-KG) and malate (Mal) which is
converted to pyruvate by the cytosolic malic enzyme (ME) and to
citrate (Cit). Cit is transported into the cytosol and converted by
ATP-dependent citrate lyase to oxaloacetate (Oxa) and acetyl-CoA
(Ac-CoA). These reactions are marked by the thick broken red arrows.
Also induced are the anabolic reactions leading to amino acids,
nucleotides, and fatty acids/lipids (indicated by the broken thick black
arrows). The non-activated metabolic reactions are marked by thin
black arrows. For abbreviations, see Figure 2.
proteins), characteristic for cancer cells. In addition, enhanced
glutaminolysis observed in many cancer cells provides necessary
TCA intermediates (Figure 4B). Furthermore, these cells, but also
primary macrophages (bone marrow- or blood-derived) used in
infection studies, are normally cultured in rich media, contain-
ing high levels of glucose, amino acids (especially glutamine) and
growth factors. Thus, many cellular nutrient transporters, cen-
tral pathways involved in carbon and nitrogen metabolism and
regulators controlling these processes will be already activated
or suppressed (Wise et al., 2008; Levine and Puzio-Kuter, 2010).
These metabolic conditions are quite different to those of pri-
mary cells encountered by the bacterial pathogens as host cells
in in vivo infections (Chen and Russo, 2012). Therefore, essen-
tial metabolic pathways activated by certain bacterial pathogens
in primary cells may not be further activated or even inhibited
in cancer cells (or otherwise metabolically activated host cells) by
the same pathogens.
The use of protists and invertebrates as infection models
may pose another problem for unraveling metabolic host (cell)
responses, since metabolic processes of these cells may differ
from those of mammalian cells in some aspects, e.g., lack of
components of the regulatory network of carbon and nitro-
gen metabolism. Hence, metabolic responses in these alternative
infection models may be quite different from those observed in
infected mammalian cells.
COMMON AND SPECIFIC METABOLIC HOST REACTIONS
TRIGGERED BY BACTERIAL PATHOGENS (GENERAL
CONSIDERATIONS)
Many bacteria (pathogenic and non-pathogenic) trigger
metabolic host responses that are primarily directed toward
inhibition of survival and proliferation of the bacteria. As shown
by numerous transcriptome studies (carried out in established
mammalian cell lines, primary phagocytes, or different animal
infection models), many of these metabolic responses are unspe-
cific, i.e., they occur with most extracellular and intracellular
bacterial pathogens and even with non-pathogenic or killed
bacteria and are therefore termed “core host responses” (Boldrick
et al., 2002). PHOX generating ROS and the iNOS generating
RNI belong to these general metabolic strategies (manifested
especially in phagocytic cells), aimed at defending the host
against bacteria (Lowenstein and Padalko, 2004; Fang, 2011).
Numerous “core response genes” are regulated by NF-κB (Nau
et al., 2002). NF-κB is activated (especially in phagocytic cells,
an important host cell type in the interaction with bacteria)
predominantly by bacterial pathogen-associated molecular
patterns (PAMPs, representing mainly common cell envelope
components, flagella, CpG DNA motifs, dsRNA) via different
Toll-like or NOD-like receptors (TLR or NLR) (Shaw et al., 2008;
Kawai and Akira, 2011). Several of the known PAMP-induced
NF-κB up-regulated genes encode also enzymes catalyzing
important metabolic reactions, including: (a) heme oxygenase-1
(HO-1) which generates carbon monoxide (CO) from heme
and thereby protects endothelial cells (EC) from tumor necrosis
factor alpha (TNF-α)-mediated apoptosis (Brouard et al., 2002),
(b) transporters for Ca2+ and other divalent metal ions (ATP2B1;
NRAMP2) and for L-amino acids (SLC7A5), (c) adenosine- and
adenosine-monophosphate deaminases (ADA, AMPD3), and (d)
indolamine-2,3-dioxygenase (IDO).
Furthermore, NF-κB is also involved in control of energy
homeostasis and metabolic adaptations by upregulating mito-
chondrial respiration (Mauro et al., 2011) and glutamine
metabolism by decreasing miR-23a expression (Rathore et al.,
2012) in a similar manner as Myc. This miRNA represses trans-
lation of the mRNA for glutaminase (GLS). In addition, NF-κB
seems to participate in the control GLS activity (Erickson and
Cerione, 2010).
Major NF-κB down-regulated “metabolic core genes” encode
(a) the nucleoside transporter (SLC29A1), (b) enzymes fur-
ther metabolizing TCA intermediates, like the cytosolic isoc-
itrate dehydrogenase (IDH2) and malic enzyme (ME1), (c)
glycogen phosphorylase (PYGL), and (d) the catalytic subunit
of glutamate/cysteine ligase (GLCLC) involved in glutathione
biosynthesis.
Further common “metabolic” genes are involved in
(chole)sterol homeostasis, including the up-regulated gene
HSD11B1 and the down-regulated gene HSD17B4. Another
apparently general host response to bacterial pathogens is the
activation of the transcription factor HIF-1 by stabilization of the
HIF-1α subunit through hypoxic conditions caused by infections
or pathogen-induced signaling (Rupp et al., 2007; Werth et al.,
2010). As described above, HIF-1 controls the transcription of
a large number of genes, including genes whose products are
involved in glucose uptake and GL.
Together, the metabolic host cell responses triggered by bacte-
rial pathogens that are determined by the “core response genes”
aim primarily at increasing antimicrobial activities and decreas-
ingmetabolic reactions thatmay provide essential nutrients to the
pathogens, thus inhibiting their proliferation (termed “nutriprive
mechanisms”) (Appelberg, 2006).
However, bacterial pathogens may also trigger infection-
promoting metabolic host responses that counteract these lat-
ter antimicrobial reactions of the host and provide protection
and/or increased nutrient supply to the pathogen. These latter
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host reactions, that are still poorly investigated so far, seem to
be induced mainly by pathogen-specific factors. Such metabolic
host responses are expected to be different for extracellular and
intracellular bacterial pathogens. Extracellular pathogens may
influence the host cell metabolism mainly by cell-associated or
secreted toxins, adhesins, and exoenzymes or by effector pro-
teins that are translocated into host cells especially via type III
or IV secretion systems (e.g., in Yersinia spp., enteropathogenic
and enterohemorrhagic E. coli, Pseudomonas aeruginosa). These
bacterial compounds may interact with different host cell targets,
e.g., components of signaling pathways or transcription factors
(e.g., PI3K/AKT; see Figure 3) controlling directly or indirectly
host cell metabolism (for reviews see Aktories and Barbieri, 2005;
Baldwin and Barbieri, 2005; Aktories, 2011; Dean, 2011).
Intracellular bacterial pathogens may influence (similar to
extracellular pathogens) host cell activities prior to invasion
already from the outside (Figure 1) by cell-toxic and -adhesive
components and/or by effector proteins that are again injected
into host cells especially by type III or IV secretion systems
(e.g., Salmonella enterica, Legionella pneumophila, Chlamydia spp;
reviewed by Haenssler and Isberg, 2011). Once internalized, these
bacteria interfere with the host cell metabolism directly as their
proliferation depends on energy sources and metabolites that
are either imported or produced by the host cells (reviewed by
Eisenreich et al., 2010; Fuchs et al., 2012). The resulting metabolic
adaptations of host cells to intracellular bacteria may differ in
each case, depending on the specific properties of the two inter-
acting partners. On the part of the bacteria, it is especially the
specific metabolic capacities and the specific virulence factors. On
the part of the host cells, it is the specific antimicrobial defense
mechanisms.
Despite the high relevance of this aspect for the understand-
ing of bacterial pathogenesis, only little information is so far
available on changes in the metabolic networks of the major tar-
get host cells (e.g., DCs, macrophages, gut epithelial cells, ECs,
liver cells) triggered by bacterial pathogens. Since the analysis of
metabolic host responses to bacterial pathogens appears to be
most advanced for the interaction between mammalian cells and
intracellular bacteria, we will focus our discussion in the follow-
ing on the metabolic host responses triggered by some important
human intracellular bacterial pathogens in cell cultures and in
in vivo infection models.
METABOLIC HOST RESPONSES TO SELECTED
INTRACELLULAR BACTERIAL PATHOGENS
METABOLIC HOST RESPONSES TO Salmonella enterica serovar
Typhimurium
Salmonella enterica serovar Typhimurium (in the following
abbreviated S. Typhimurium) is a leading cause of gastroin-
testinal infections in humans and livestock (Mead et al., 1999;
Herikstad et al., 2002). In the mouse model, S. Typhimurium
leads to systemic infections comparable to S. Typhi infections
in humans (Tam et al., 2008). The pathogen triggers intestinal
inflammation which enhances growth in the intestinal lumen
and supports invasion of the intestinal epithelium and mucosal
macrophages (Stecher et al., 2007; Santos et al., 2009). After
crossing the intestinal epithelium, S. Typhimurium is taken up
primarily by DCs.Within DCs, salmonellae survive without repli-
cation (Niedergang et al., 2000; Jantsch et al., 2003) and are
transported to the mesenteric lymph node (MLN). There, they
can exit and spread as free bacteria or within cells to other tis-
sues (especially liver and spleen) of the infected mammalian hosts
(Paulin et al., 2002; Pullinger et al., 2007).
In vitro studies
Numerous “omics”-studies (in particular transcriptome, but also
proteome and metabolome analyses) were performed with differ-
ent host cells and animal (mainly mouse) models infected with
S. Typhimurium (Rosenberger et al., 2000; Detweiler et al., 2001;
Handley and Miller, 2007; Karavolos et al., 2008; Wang et al.,
2008; Liu et al., 2010a; Antunes et al., 2011).
Not unexpectedly, transcriptome studies on Salmonella-
infected mammalian cell lines did not yield much information
concerning specific metabolic host responses, i.e., no apparent
differential expression of metabolic genes was reported when
transcript profilingwas performed with S. Typhimurium-infected
human macrophage-like U937-1 cells (Detweiler et al., 2001).
Infected murine macrophage-like RAW 264.7 cells compared
to the un-infected control cells showed only up-regulation of
iNOS and GLUT1, encoding NO synthase and Glut1, respectively
(Rosenberger et al., 2000). In a proteomic study using RAW 264.7
cells infected with S. Typhimurium, increased levels of iNOS and
inducible cyclooxygenase 2 (COX2; converting arachidonic acid
to prostaglandin) were observed 24 h post-infection (Shi et al.,
2009).
In vivo studies
S. Typhimurium-infected animal models provide more rele-
vant data regarding metabolic host responses. A global differ-
ential gene expression study in the mouse colon mucosa during
S. Typhimurium infection (Liu et al., 2010a) suggests the com-
plete shut-off of the oxidative phosphorylation early in infection
(8 h) and the down-regulation of genes of many metabolic path-
ways, mainly at later times of infection (4 days). Among those,
catabolism of glucose and branched chain amino acids (Val, Leu,
Ile) seem to be most significantly affected. Interestingly, several
genes involved in mTOR signaling are up-regulated.
Cawthraw et al. (2011) analyzed the gene expression profiles
induced by S. Enteritidis in wild-type C3H/HeN mice and more
susceptible TLR4-deficient C3H/HeJ (and BALB/c) mice. In the
susceptible mice, more metabolic pathways seem to be affected by
the infection than in the wild-type mice, including in particular
GL and GN. The response to S. Enteritidis in the intestine is, in
general, much weaker than the in vitro response in murine rectal
epithelial cells (CTM93/09 cells), suggesting a tighter control of
the metabolic responses to S. Enteritidis in the intestine than in
the isolated cells (Cawthraw et al., 2011).
An interesting study on metabolic changes in C57BL/6 mice
upon S. Typhimurium infection was reported (Antunes et al.,
2011) using a metabolomics approach. By measuring the altered
concentration of metabolites in infected and uninfected intes-
tine and liver, the authors showed that production of many
metabolites (including carbohydrates, bile acids, steroids, and
eicosanoids among others) are induced or repressed in the
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samples of the infected mice compared to the uninfected con-
trol mice. Most metabolites, derived from primary glucose
metabolism (GL, GN, PPP) but also from specific pathways for
other carbohydrates (fructose, mannose, galactose, starch, and
sucrose), decreased in the liver but not in the intestine upon
infection. Whether this finding reflects the high energy expendi-
ture that is required to fight the infection (as suggested by the
authors) or a general inhibition of the carbon metabolism in
the liver as a result of the S. Typhimurium infection remains,
however, unanswered. In contrast, a highly increased concentra-
tion of metabolites involved in the arachidonic pathway (leading
to eicosanoid hormones) and the C21-steroid hormone path-
way was observed, suggesting that the S. Typhimurium infection
strongly disturbs the steroid and eicosanoid hormonemetabolism
of the host. Some of these hormones are known regulators of
carbohydrate metabolism and of immune responses (Vinson,
2009).
As mentioned above, activation of HIF-1 due to hypoxic con-
ditions arising in infections by human pathogens seems to be a
rather general phenomenon (Werth et al., 2010), which causes
increased glucose uptake and GL in most host cells infected
by intracellular bacteria. However, hypoxia-independent activa-
tion of HIF-1α has also been demonstrated in Peyer’s patches
of the mice infected by different enterobacteriaceae, including
S. Typhimurium. The pathogen-specific siderophores (salmoche-
lin in case of S.Typhimurium) seem to be responsible for this acti-
vation leading to induction of several HIF-1-dependentmetabolic
genes, including genes for the glycolytic enzymes, hexokinase and
phosphofructokinase, as well as carbonic anhydrase, observed
in Peyer’s patches after orogastric S. Typhimurium infection
(Hartmann et al., 2008).
S. Typhimurium-infected macrophages reduce the host cell’s
iron pool by causing iron efflux from phagosomes via induced
SLC11A1 (NRAMP1) (Cellier et al., 2007; Nairz et al., 2009).
Subsequently, the resulting low intracellular iron concentration
triggers the expression of the highly efficient iron-uptake systems
in S. Typhimurium. This allows the bacteria to compete success-
fully for the remaining iron supply thus promoting their growth
within the macrophages. Moreover, strong down-regulation of
the gene encoding the plasma membrane calcium-transporting
ATPase (PMCA) occurs in bovine Peyer’ patches early in infec-
tion (Santos et al., 2002), thus increasing the cellular calcium level
which affects various metabolic processes, including enhanced
mitochondrial ATP synthesis (Jouaville et al., 1999).
As described above, PHOX generating ROS and iNOS gen-
erating RNI are general metabolic strategies (manifested espe-
cially in phagocytic cells) against bacterial pathogens, including
Salmonella. Silencing of these reactive agents may be therefore
advantageous for the pathogen. S. Typhimurium is able to sub-
vert these metabolic host defense reactions by different strate-
gies (MacFarlane et al., 1999; Shiloh et al., 1999; Mastroeni
et al., 2000). These include: (a) Reduction of the host iNOS-
catalyzed RNI production through induction of the arginase
isoform II in the spleen of infected mice. The arginase competes
with iNOS for the same substrate (arginine) and thus reduces
iNOS-mediated NO production which increases the prolifera-
tion of S. Typhimurium in the lymphoid organs of infected mice
(Lahiri et al., 2008); (b) Induction of arginine uptake through
enhanced expression of the genes encoding the cationic amino
acids transporters (CAT1 and CAT2) in isolated bone marrow-
derived macrophages (BMDMs) and DCs, but also in liver and
spleen of infected mice (Das et al., 2010). The increased arginine
level may lead to an increase of NO production by iNOS and
hence to reinforced antimicrobial activity. However, these host
cell transporters are recruited preferentially to the Salmonella-
containing vacuole (SCV) thus channeling arginine into the SCV
thereby supporting growth of S. Typhimurium. For this goal,
S. Typhimurium induces in addition the expression of the gene
coding for its own arginine transporter ArgT (Das et al., 2010);
(c) Using ROS (whose production is induced during Salmonella
infections due to activated host cell NADPH oxidase) for its own
proliferation in the intestinal lumen. ROS trigger the formation
of tetrathionate (S4O
2−
6 ) from thiosulphate (S2O
2−
3 ) enriched in
the intestine. Tetrathionate (but not thiosulphate) can be used
by S. Typhimurium as electron acceptor for efficient anaerobic
respiration (Winter et al., 2010).
Effector proteins as possible modifiers of host cell metabolism
All Salmonella enterica serovars infecting warm-blooded animals
express two T3SSs, encoded by SPI-1 and SPI-2, respectively,
which translocate specific sets of effector proteins into the host
cells cytosol (for a recent review, see Moest and Méresse, 2013).
While SPI-1 effectors appear to mainly trigger internalization
of Salmonella by non-professional phagocytes, the SPI-2 effec-
tors are needed for intracellular replication. Interestingly, recent
data suggest that some of these effectors may also be involved in
modifying the metabolism of the infected cells.
As shown (Knodler et al., 2005), S. Typhimurium residing
in the SCV translocates SopB which activates Akt. This activa-
tion occurs within minutes after invasion and lasts for several
hours. The Akt activation seems to be involved in the inhibition
of apoptosis of the infected host cells (Knodler et al., 2005) and is
essential for Salmonella (and Mycobacterium tuberculosis) infec-
tion of epithelial cells and macrophages (Kuijl et al., 2007). As
discussed above, activated Akt phosphorylates Mdm2, a key regu-
lator of p53 stability. Activated Mdm2 ubiquitinates p53 and thus
promotes p53 degradation which may in turn stimulate glucose
flux via GL.
AvrA, another Salmonella T3SS-translocated effector protein
(Hardt and Galán, 1997), could also be responsible—either
directly or indirectly—for some of the specific Salmonella-
induced metabolic host responses. As shown (Liu et al., 2010b),
AvrA leads to reduction of oxidative phosphorylation and to acti-
vation of mTOR, NF-κB and p53 in intestinal in vivo infection.
The activation of p53 is caused by AvrA-mediated p53 acetylation
(Wu et al., 2010). While activated p53 will inhibit GL, acti-
vated mTOR may stimulate amino acids uptake and catabolism.
Thus, the AvrA-mediated activation of these regulators may
again modify the carbon metabolism of Salmonella-infected host
cells.
In a recent study, Lopez and collegues showed that
S. Typhimurium strains expressing the type III effector protein
SopE (encoded by a lysogenic phage present in several epi-
demic strains) triggers the synthesis of iNOS in the host cells
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intestine (Lopez et al., 2012). The thereby produced nitric oxide
is converted to nitrate in the host cell which acts as an even
better electron acceptor in anaerobic nitrate respiration than
S4O
2−
6 in tetrathionate respiration. Under these respiratory con-
ditions, S. Typhimurium is able to use the non-fermentable
carbon source ethanolamine (Thiennimitr et al., 2011), a nutri-
ent deriving from phosphatidylethanolamine that is present in
the intestine (Bertin et al., 2011). This metabolic capability gen-
erates a growth advantage for S. Typhimurium over the inher-
ent anaerobic intestinal microbiota that is unable to respire
ethanolamine.
Salmonella infection of murine macrophage-like cell lines
(RAW264.7 and J774A.1) induces the expression of COX2
(Uchiya and Nikai, 2004; Shi et al., 2009). This induction depends
on the Salmonella protein SpiC, a gene product encoded within
SPI-2 and translocated into host cells by T3SS-2 (Uchiya and
Nikai, 2004). COX2 encodes cyclooxygenase 2, a key enzyme
involved of prostanoid synthesis which leads to an increased pro-
duction of PGE2 and PGI2, two prostanoids belonging to the
eicosanoid hormones.
In summary, a plethora of in vitro and in vivo studies shows—
albeit with still rather fragmentary evidence—that Salmonella
infection leads to numerous changes of the carbon and nitro-
gen metabolism in the infected host (cells), which on one hand
may prolong the host cell’s survival and on the other hand may
support the pathogen’s proliferation. These metabolic changes
of the host (cells) are caused by common and specific compo-
nents of the pathogen. Especially the latter host cell responses
are observed in in vivo models, but hardly in established cell
lines. Multiple-task effector proteins, e.g., SopB, AvrA, SopE,
may also be responsible for the specific changes in host cell
carbon and nitrogen metabolism, by interfering with global reg-
ulators of the host cell’s metabolism, like p53 and mTOR. Clearly,
further studies are necessary to fully understand the impact
of Salmonella infection on the complex metabolic network of
the host and to unravel which Salmonella effectors are respon-
sible for the observed specific metabolic changes of the host
cells.
METABOLIC HOST RESPONSES TOMycobacterium tuberculosis
The facultative intracellular pathogen M. tuberculosis belongs
to the few bacterial pathogens for which humans are the only
known reservoir, although it may infect mice and even amoe-
bae (Hagedorn et al., 2009). M. tuberculosis colonizes the lung
as major target organ, causing pulmonary tuberculosis (TB).
Macrophages are the primary intracellular niches to which
M. tuberculosis has adapted. Within these host cells, M. tuber-
culosis survives and replicates in a specialized phagosomal com-
partment. Under certain conditions, the bacteria seem to be able
to escape into the host cells cytosol (van der Wel et al., 2007).
Shortly after infection, granuloma are formed comprising a core
of infected macrophages, surrounded by foamy macrophages,
monocytes, and multinucleated giant cells (Russell, 2007). Under
immunocompromised conditions,M. tuberculosis may also infect
other organs, causing extrapulmonary TB. The visceral adipose
tissue has been proposed as an important reservoir for persistence
of M. tuberculosis (Neyrolles et al., 2006).
Because of its medical importance, extensive effort has been
made to understand the complex metabolism of M. tuberculosis
under in vitro and in vivo conditions. This aspect is far from being
completely solved (Rhee et al., 2011), but the metabolic responses
of the target host cells and tissues to M. tuberculosis infections are
even less understood. Numerous studies using transcript profiling
were performed with infected host cells (mainly macrophages)
and mice (Ehrt et al., 2001; Wang et al., 2003; Kendall et al., 2004;
Volpe et al., 2006). In addition, proteomics and metabolomics
studies were applied to M. tuberculosis-infected cells and animal
models (Shui et al., 2009; de Carvalho et al., 2010; Somashekar
et al., 2011, 2012). These studies allowed important insights into
immune responses induced by M. tuberculosis, but also provided
some clues how M. tuberculosis modulates metabolic processes of
the infected host cells.
In vitro studies
Most of the observed metabolic changes in M. tuberculosis-
infected host cells are again linked to defensemechanisms, includ-
ing oxidative stress and production of antimicrobial peptides.
Macrophages can inhibit M. tuberculosis replication by iNOS-
generated RNI (Adams et al., 1997). This enzyme is induced
upon M. tuberculosis infection of macrophages (Ehrt et al., 2001).
Induction of PHOX, leading to increased levels of ROS has also
been reported (Wang et al., 2003; Shui et al., 2009). Yet, M. tuber-
culosis is relatively resistant to killing by ROS as these ROS are
inactivated by the induced mycobacterial catalase KatG (Ng et al.,
2004) which has catalase and peroxidase activity (Heym et al.,
1993). M. tuberculosis infection also stimulates expression of
heme oxygenase (HO-1) in mouse macrophages and other host
cells, probably via the TNF-α signaling pathway (Shiloh et al.,
2008). CO, one of the reaction products of HO-1, together with
NO generated by iNOS, seems to induce transcription of the Mtb
dormancy regulon via the two-component systemDosS/T (Shiloh
et al., 2008). Furthermore, increased levels of host cell proteins
involved in the generation of ROS, like the p67phox subunit of
NADPH oxidase and the neutrophil cytosolic factor 1 (NCF1 or
p47) required for activation of NADPH oxidase are observed.
Finally, the production of the Mn-dependent superoxide dismu-
tase, acting as an antioxidant (by quenching ROS and hydrogen
peroxide) is up-regulated.
The unique mycobacterial cell wall lipids play an important
role inM. tuberculosis pathogenesis processes (Russell et al., 2002;
Korf et al., 2005). Exposure of J774A.1 macrophage-like cells
to M. tuberculosis lipids results in a total of 166 differentially
expressed macrophage proteins (Shui et al., 2009). A substantial
portion of the differentially expressed proteins (14%) seem to be
involved in metabolism, but the functions of these proteins are
not further elaborated.
In vivo studies
Progression of human TB leads to the development of
caseous pulmonary granuloma, comprising a core of infected
macrophages. Previous reports show an abundance of lipid
species (mainly cholesterol, cholesterol ester, and triacylglycerol)
in these cells of M. tuberculosis-infected mice and TB patients
(Garner et al., 2002; Hunter et al., 2007). Transcriptome analysis
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of such TB granuloma reveals significant up-regulation of genes
involved in sequestration, catabolism, and synthesis of host lipids
(Kim et al., 2010). Many of the up-regulated genes are also
induced by TNF-α, indicating that this response may be caused
by the sustained inflammation triggered mainly by M. tubercu-
losis cell wall components. The thereby accumulated lipids could
serve as suitable carbon source for M. tuberculosis colonizing the
granuloma in a dormant state.
Important information on metabolic host changes is pro-
vided by recent 1H-NMR-based metabolite profiling studies
from the mouse and guinea pig M. tuberculosis infection mod-
els (Shin et al., 2011; Somashekar et al., 2011). The infected
mice show qualitatively similar changes of major catabolic and
anabolic metabolites in all tissues tested (lung, liver, and spleen).
Quantitatively, the most significant effects are observed in the
lung, the major target of M. tuberculosis infection. The levels of
glucose and glycogen as well as those of NAD andNADPdecrease,
while lactate concentration increases, suggesting increased con-
sumption of glucose via GL and the pentose-phosphate shunt.
The decreased level of the TCA cycle intermediates OXA and
fumarate, suggesting reduced activity of the TCA cycle, sup-
ports this assumption. Yet, the level of succinate, another TCA
cycle intermediate increases. This elevated amount of succinate
may be generated by enhanced glutaminolysis in mitochondria
induced by the oxidative stress occurring during M. tuberculosis
infection (see above) (Fedotcheva et al., 2006). Alternatively, suc-
cinate may be secreted byM. tuberculosis. As shown (Muñoz-Elías
and McKinney, 2005), bacterial production of succinate could
increase due to the induction of the glyoxylate and methylcitrate
cycles caused by switching theM. tuberculosis carbon metabolism
toward β-oxidation of fatty acids due to the enhanced lipoly-
sis in the host cells. Interestingly, the amount of many amino
acids also increases in the analyzed tissues and even in serum of
the M. tuberculosis-infected mice, suggesting enhanced proteol-
ysis and/or catabolism of ingested amino acids. This metabolic
change might be related to the “anabolic block” observed in TB
patients (Macallan et al., 1998).
Furthermore, increased amounts of several intermediates of
pyrimidine and purine nucleotide biosynthesis are observed in
the lung which is taken as evidence that cells in the M. tubercu-
losis-infected lung actively divide (Shin et al., 2011). An increased
level of the antioxidant glutathione (GSH) is also observed in the
infected lung (and spleen) and probably represents an additional
metabolic defense reaction against the induced oxidative stress.
Metabolite profiling of the lung tissues and serum of infected
guinea pigs (Somashekar et al., 2011) reveal similar patterns of
metabolites as in the infected mice, also suggesting enhanced
GL, glutaminolysis and GN triggered by the M. tuberculosis
infection.
In summary, M. tuberculosis infection causes strong metabolic
host responses concerning host defense against the infection, but
also enhanced lipid metabolism, glucose consumption, and pro-
teolysis. These metabolic host responses, observed again mainly
in the in vivo (mouse and guinea pig) models, seem to support
intracellular replication of M. tuberculosis. The unique mycobac-
terial cell wall components apparently play a major role in most
of the observed metabolic host responses.
METABOLIC HOST RESPONSE TO Listeria monocytogenes
The Gram-positive facultative intracellular bacterium L. monocy-
togenes is the only species of the genus Listeria that is pathogenic
for humans, whereas the other members are either pathogenic
only to animals (L. ivanovii) or are harmless saprophytes liv-
ing mainly in natural environments. Clinical symptoms of
L. monocytogenes infections range from febrile gastroenteritis
to encephalomeningitis, sepsis, and abortion. L. monocytogenes
escapes from the phagosome and replicates primarily in the
host cells cytosol, but replication in so-called spacious Listeria-
containing phagosomes (SLAPs) may also occur (Birmingham
et al., 2008). The latter mode of intracellular listerial replication
is dependent on the recruitment of the autophagy protein LC3
to the phagosome and low production of listeriolysin (LLO). The
mechanism of action of this and the other virulence factors of
L. monocytogenes has been extensively studied on the molecular
level using appropriate cellular and animal model systems (for
recent reviews, see Camejo et al., 2011; Stavru et al., 2011). The
expression of most of these virulence factors is induced within
the infected host cells (reviewed by de las Heras et al., 2011).
In vitro studies
Genes involved in metabolism (with the exception of HIF-
1α) are apparently not differentially expressed in the human
macrophage-like cell line THP-1 upon L. monocytogenes infection
(Cohen et al., 2000). This result may be in part the consequence
of the incomplete gene array used in this study, but—more
likely—is again due to the already upregulated metabolism of
the used THP-1 cells (even in the uninfected state—see above).
This assumption is supported by recent 13C-isotopologue stud-
ies, carried out with primary murine bone marrow-derived
macrophages (BMM) and the murine macrophage-like J774A.1
cells infected with L. monocytogenes (Gillmaier et al., 2012). When
the two cell types are fed with uniformly 13C-labeled glucose
or 13C-labeled glutamine, high induction of glucose uptake and
GL is observed in BMM upon infection with L. monocytogenes,
but not in the J774A.1 cells (which already show up-regulated
GL and glutaminolysis in the un-infected state). In contrast, the
activity of the TCA cycle and glutaminolysis remains unaffected
in the L. monocytogenes-infected BMM. The L. monocytogenes-
induced carbon metabolism in BMM allows a similarly efficient
proliferation of the internalized bacteria in BMM as in J774A.1
cells.
In vivo studies
In mice expressing humanized E-cadherin, the host response was
analysed by transcript profiling of the intestinal epithelia after
infection with a L. monocytogenes wild-type strain and compared
to the response of germ-free mice and of mice infected with a
non-pathogenic L. innocua strain (Lecuit et al., 2007). The sup-
plementary part of this report provides interesting data concern-
ing specific L. monocytogenes-induced metabolic host responses.
Transcription of most GL genes is enhanced after infection, but
the gene encoding hexosekinase II (HKII) shows the highest
increase (about 10-fold). This suggests that glucose taken up
is mostly phosphorylated by HK-II, which has easy access to
ATP due to its close association to mitochondria. The product,
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glucose-6P, is an important carbon substrate for intracellular
L. monocytogenes in epithelial cells and macrophages (Chico-
Calero et al., 2002; Eylert et al., 2008). The enhanced glucose-6P
production will be therefore advantageous for the cytosolic pro-
liferation of L. monocytogenes. The induced expression of the GL
genes and of the gene for lactate dehydrogenase may be linked to
the observed enhanced HIF-1α gene expression. In line with the
increased expression of the GL genes is the down-regulation of
the genes for fructose bisphosphatases 1 and 2 (playing a cen-
tral role in GN) and of glutamate dehydrogenase (involved in
glutaminolysis). Transcription of the genes encoding pyruvate
dehydrogenase and citrate synthase is also increased while all
other genes encoding TCA cycle enzymes and the genes involved
in the electron transfer chain (ETC) are not differentially regu-
lated. Possibly, the produced citrate is mainly transported into the
cytosol and converted by ATP-dependent citrate lyase into OXA
and acetyl-CoA and used for biosynthesis of aspartate and fatty
acids, respectively. There is also a remarkable up-regulation of
genes encoding key enzymes involved in the biosynthesis of serine
(phosphoserine aminotransferase) and asparagine (asparagine
synthetase). The observed metabolic host responses appear to be
triggered by intracellular listeriae since a non-invasive inlA, inlB
mutant does not cause up-regulation of these genes. This suggests
that secreted listerial virulence factors whose synthesis is induced
under intracellular conditions may modulate the metabolic host
responses observed in this in vivo study and also in the above
described 13C-isotopolog studies with L. monocytogenes-infected
primary mouse macrophages. The two phospholipases C (PlcA
and PlcB) and listeriolysin are potential candidates, as they were
shown to interact with signaling pathways of mammalian cells
(Goldfine andWadsworth, 2002; Kayal and Charbit, 2006; Gekara
et al., 2008).
Another notable result of this in vivo transcriptome anal-
ysis is the dramatic down-regulation of several CYP genes
encoding members of the cytochrome P450 families which
represent monooxygenases catalyzing mainly the hydroxylation
of steroid and eicosanoid substrates (Marohnic et al., 2006).
The CYP genes that are most strongly down-regulated in the
L. monocytogenes-infected mouse intestinal epithelium encode
monooxygenases involved in biosynthesis of oxysterols and bile
acids (Pikuleva, 2006). In this context, recent data (Zou et al.,
2011) is of interest showing that L. monocytogenes triggers the
up-regulation of Ch25h in macrophages. This gene encodes
cholesterol 25-hydroxylase responsible for the formation of 25-
hydroxycholesterol from cholesterol. Increased levels of Ch25h
support survival of L. monocytogenes-infected cells (Zou et al.,
2011). In accord with this assumption is the strong down-
regulation of CYP39A1 encoding a hydroxylase that converts
cholesterol via the 24-cholesterol pathway and thus reduces the
formation of 25-hydroxycholesterol.
As expected, transcriptional up-regulation of the genes encod-
ing iNOS and IDO (indolylamine 2,3-dioxygenase) is also
observed which in conjunction with the transcriptional down-
regulation of the genes for arginase type II (competing with iNOS
for Arg) and catalase supports host defense reactions against
L. monocytogenes. This finding is in accord with results of another
study (Sonje et al., 2010) also showing highly increased expression
of iNOS and IDO in neonatal mice upon infection with L. mono-
cytogenes. It should be noted, however, that induced expression of
these genes occurs even in TNF receptor 1 (TNFR1) knock-out
mice, which are highly susceptible for L. monocytgenes infection.
This indicates that increased levels of iNOS and IDO do not suf-
fice to cause antilisterial protection and that TNF-α signaling is
absolutely needed for protection against L. monocytogenes.
In summary, L. monocytogenes has a strong impact on the
host cell metabolism, especially when internalized by mammalian
host cells. Some of the virulence factors, notably LLO and the
two phospholipases, may be responsible for at least some of the
observed metabolic host responses. Especially the studies with
L. monocytogenes-infected “humanized” mice and with primary
mouse macrophages show that L. monocytogenes induces reac-
tions of the host cell carbon metabolism that favor uptake of
glucose and the production of compounds, such as glucose-6P,
serine, and glycerol, which are preferably utilized by the bacte-
ria for their own intracellular metabolism (Eylert et al., 2008).
Furthermore, the internalized bacteria appear to trigger a striking
change of the host cell steroid metabolism that may also sup-
port intracellular survival (e.g., by causing LLO activation, and/or
reduced bile acid formation).
METABOLIC HOST RESPONSE TO Chlamydia spp.
The genus Chlamydia comprises several obligate intracellular
species. Among those, C. trachomatis is the most extensively
studied. In humans, C. trachomatis infects ocular and urogenital
epithelial tissues and causes trachoma and sexually transmitted
diseases (Byrne, 2010). All Chlamydia species exhibit a partially
disrupted primary carbon metabolism and lack most anabolic
pathways. Hence, intracellular chlamydiae have to take upmost of
the required metabolites and energy from the host cell (McClarty,
1994; Fuchs et al., 2012). Amino acids seem to be the major car-
bon and energy source for the impaired metabolic activities of
the intracellular chlamydiae. Amino acids may be provided to
the bacteria by the host cell through lysosomal degradation of
external proteins (Ouellette et al., 2011). In addition, the chlamy-
dial proteases CPAF and cHtrA are secreted into the host cells
cytosol where they may degrade host proteins (Zhong et al., 2001;
Wu et al., 2011; Chen et al., 2012). For sustaining a stable host-
parasite interaction, the host cell has to substantially re-adjust its
metabolism upon infection with chlamydiae.
Studies with Chlamydia-infected host cells and tissues
Since there are no suitable animal models for Chlamydia, all gene
expression profiling studies reporting on host cell responses to
chlamydial infections are performed with infected cell lines and
tissues (e.g., Stephens, 2003; Alvesalo et al., 2008; Amirshahi et al.,
2011). Not unexpectedly, these studies provide only little infor-
mation on differentially expressed metabolic genes. In Hep-2 cells
infected with C. pneumoniae, induction of host cell genes involved
in glucose uptake and GL is observed, caused (at least in part) by
hypoxia-mediated HIF-1α stabilization (Rupp et al., 2007; Werth
et al., 2010).
Host-cell derived lipids, especially sphingomyelin, are essential
for intracellular growth ofC. trachomatis and the formation of the
inclusion body. Reactivation of persistent C. trachomatis requires
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the induced host cell sphingolipid biosynthesis (Robertson et al.,
2009). The enhanced lipid biosynthesis in the host cells relies on
higher NADPH consumption which may explain the preferential
glucose flux through the PPP observed in C. trachomatis-infected
cells (Fukuda et al., 2005; Szaszák et al., 2011).
A recent gene expression analysis in conjunctival swab samples
of patients with active trachoma and healthy controls (Natividad
et al., 2010) provides (mainly in the Supplementary Material
part) a plethora of interesting data on differentially expressed
metabolic genes that may shed light on the metabolic host
responses to C. trachomatis infection. Of particular note is the
highly up-regulated transcription of many genes encoding nutri-
ent transporters, i.e., transporters for glucose, including mem-
bers of the SLGT family (e.g., SLC5) and the GLUT family
(e.g., SLC2A3, SLC2, SLC2A14, SLC2A5), for cationic, neutral,
and aromatic amino acids (e.g., SLC7A11, SLC14A4, SLC16A,
SLC1A4, SLC7A11), for peptides (SLC15A3), for metal ions
(e.g., SLC39A8, SLC8A1, SLC24A, SLC11A1), for glycerol-3P
(SLC37A) and for nucleosides (SLC38A3). Assuming a corre-
spondingly increased translation of these transcripts, the data
suggest that induction of transporters required for the uptake of
nutrients essential for intracellular growth is a strong metabolic
host response to a chlamydial infection. It will be interesting
to find out whether these transporter proteins are incorpo-
rated into the host cell cytoplasmic membrane or recruited to
the Chlamydia containing vacuole (“inclusion body”). Not sur-
prisingly, none of these transporter genes upregulated in the
tissue samples have been found differentially expressed in pro-
ductively and persistently Chlamydia-infected HeLa or HL cells
using transcriptomic (Eickhoff et al., 2007; Alvesalo et al., 2008)
or proteomic approaches (Savijoki et al., 2008). As discussed
above, nutrient uptake is already induced in these transformed
cell lines. Indeed, expression of amino acid transporter genes and
of other metabolic genes seems to be even down-regulated in
these transformed host cells upon infection with C. pneumoniae
(Alvesalo et al., 2008).
As expected, increased expression of genes encoding NADPH
oxidase and iNOS is also observed in the above gene expression
analysis of the patients’ tissue samples. This causes enhanced pro-
duction of ROS and RNI which may support the host defense
against the intracellular Chlamydia. The enhanced expression of
the host genes for superoxide dismutase (SOD2) and arginase II
(ARG2) probably protects the host cells against the cell-damaging
ROS and RNI.
In summary, the metabolic host cell responses to chlamy-
dial infections are highlighted by increased glucose uptake and
glucose flux through GL. The pentose-phosphate shunt is also
induced andmay be linked to the enhanced anabolic performance
(increased protein and lipid synthesis) of the host cells observed
during the proliferative phase of the chlamydial infection. The
remarkable up-regulation of many genes encoding transporters
for nutrients needed for intracellular chlamydial growth suggests
increased import of these nutrients by the host cells and possi-
ble recruitment of these nutrient transporters to the membrane
surrounding the Chlamydia-containing vacuole (“inclusion”). So
far, nothing is known about chlamydial factors that may be
responsible for the metabolic responses of the infected host cells.
METABOLIC HOST RESPONSE TO Coxiella burnetii
C. burnetii, the etiological agent of the human disease Q fever,
belongs—like theChlamydia spp.—to the group of obligate intra-
cellular human pathogens, but replicates in acidified (pH 4.5–5)
phagolysosome-like vacuoles.
Transcriptional host response to C. burnetii infection is mainly
studied in the humanmacrophage-like cell line THP-1 (Ren et al.,
2003; Mahapatra et al., 2010). THP-1 cells, infected with C. bur-
netii or Chlamydia trachomatis, respectively, show an extensive
overlap in up- and down-regulated genes, but pathogen-specific
differential gene expression is also observed (Ren et al., 2003).
Only few of the common and species-specific differentially reg-
ulated genes are involved in host cell metabolism and none in
carbon metabolism which may be again due to the already acti-
vated primary carbon metabolism of the host cell line used (see
above).
The common up-regulated genes include SLC2A6, encoding
a facilitated transporter that can also transport glucose, TDO2,
encoding tryptophan 2,3-dioxygenase which, like indoleamine
2,3 dioxygenase (IDO), catalyzes the first step in the degrada-
tion of tryptophan, CYBB (NOX2), encoding gp91, the major
subunit of phagosomal NADPH oxidase, and FTH1 (encoding
ferritin heavy chain) which oxidizes Fe(II) to Fe (III). In addi-
tion to the transcriptional up-regulation of FTH1, C. burnetii,
unlike C. trachomatis, also induces the expression of the trans-
ferrin receptor gene (TfR) in murine macrophage-like J774A.1
cells, resulting in a 2.5-fold increase in cellular iron concentra-
tion (Howe and Mallavia, 1999). Since the metabolic activities
of C. burnetii are strongly affected by iron in vitro, this finding
suggests that the TfR up-regulation is important for the iron sup-
ply during intracellular replication of C. burnetii. In addition, the
reactions catalyzed by NOX2 and NADP oxidase may help to pro-
tect the host cells against exceeding growth of the intracellular
bacteria.
Among the host metabolic genes that are specifically up-
regulated by C. burnetii are RENBP encoding N-acylglucosamine
2-epimerase that is involved in amino sugar and nucleotide sugar
metabolism, PIR (Wendler et al., 1997) encoding the iron-binding
protein and transcriptional co-factor pirin, which is involved in
numerous cellular processes, and ATP6V1H encoding a subunit
of the V-ATPase, a vacuolar proton pump.
Changes in cellular lipids, especially in the cellular choles-
terol level, have been observed during infections by phagosomal
intracellular bacteria, including S. enterica, M. tuberculosis, and
C. burnetii (Howe and Heinzen, 2006). The up-regulation of host
genes involved in lipid metabolism in C. burnetii infected THP-1
cells (Ren et al., 2003; Mahapatra et al., 2010) is in line with this
observation.
Although both, ROS and RNI are involved in the host defense
against C. burnetii infection (Brennan et al., 2004), a hallmark in
metabolic host response to C. burnetii is the dramatic decrease
of NADPH oxidase in neutrophils (Siemsen et al., 2009) which
seems to be due to the inactivation of neutrophil NADPH oxi-
dase by phagocytosed Coxiella. A T2SS-dependent secreted acidic
phosphatase of Coxiella appears to be responsible for this pro-
cess (Hill and Samuel, 2011). Bacterial phosphatases could be
even more generally involved in silencing the NADPH oxidase by
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intracellular bacteria, as these bacteria frequently encode secreted
protein- and/or phosphoinositide-phosphatases (Tabernero et al.,
2008; Kastner et al., 2011).
C. burnetii also secretes protein effectors into the cytosol via
a T4SS that is similar to the Dot/Icm T4SS of Legionella pneu-
mophila (Carey et al., 2011). As in L. pneumophila (see below),
effector proteins have been described that modulate host cell
functions, e.g., membrane trafficking (Voth and Heinzen, 2009),
but so far no Coxiella effector has been identified that might be
involved in the modulation of host cell metabolism.
In summary, the scattered information on the metabolic host
response against Coxiella infection is mainly based on transcrip-
tome data obtained from Coxiella-infected cell lines and is hence
of limited significance, especially as far as the primary carbon
metabolism is concerned. Major host metabolic responses seem
to be the induction of iron uptake and the destruction of the
NADPH oxidase caused by Coxiella infection, two reactions that
favor the intracellular replication of these bacteria.
METABOLIC HOST RESPONSE TO Legionella pneumophila
L. pneumophila is the best studied member of the genus
Legionella. This facultative intracellular pathogen replicates
intracellularly within a specialized phagosome, the Legionella-
containing vacuole (LCV) in human alveolar macrophages and
in amoebae. Acanthamoeba castelanii and the social amoeba
Dictyostelium discoideum are well-established model organisms
for studying the L. pneumophila intracellular life style. Virulence
of L. pneumophila is most strikingly determined by the Dot/Icm
T4SS, which translocates about 300 effector proteins into the
host cell (Isberg et al., 2009). Some of these effectors partici-
pate in the remodeling of the primary phagosome to the LCV,
essential for intracellular replication, and in the manipulation
of host cell signal transduction pathways through phosphoryla-
tion/dephosphorylation reactions (for recent reviews, see Shin
and Roy, 2008; Haenssler and Isberg, 2011).
An explicit participation of translocated effectors in the mod-
ulation of the host cell’s metabolism has not yet been demon-
strated. However, some observations argue for a direct or indirect
involvement of effector proteins in metabolic processes: (a) in
macrophages and in the Dictyostelium model, Dot/Icm effectors
may play a critical role in autophagy with a possible consequence
for host cell metabolism (Otto et al., 2004; Amer et al., 2005; Tung
et al., 2010), (b) L. pneumophila-infected human macrophage-
like U937 cells activate NF-κB signaling in a Dot/Icm-dependent
manner (Losick and Isberg, 2006) by the effector protein LnaB
(Losick et al., 2010). NF-κB, well-known as an important reg-
ulator of cell survival and differentiation, is also linked to
metabolic processes, e.g., glutamine metabolism (Rathore et al.,
2012), (c) putative Dot/Icm-dependent serine/threonine protein
kinases and phosphatases may modulate the activity of metabolic
enzymes as well as host signaling pathways and possibly down-
stream metabolic processes (Chien et al., 2004; Li et al., 2009;
Hervet et al., 2011).
Comprehensive transcriptome studies on host cell response
to L. pneumophila infection are so far only available for
L. pneumophila-infected D. discoideum (Farbrother et al., 2006).
Differential expression is observed for many metabolic genes of
D. discoideum (mainly seen 24 h after infection) whose impact
on host cell metabolism is summarized by the authors in two
major conclusions: (a) enzymatic activities involved in bacterial
degradation, protein biosynthesis, and fatty acid modification are
down-regulated and (b) expression of genes involved inmetabolic
activities that ultimately generate products needed for the prolif-
eration of the pathogen is induced. Based on the data, the authors
suggest that “Legionella specifically manipulates the host by dif-
ferentially regulating its metabolism, upregulating activities that
produce nutrients suitable for the pathogen and downregulating
the host-specific metabolism.”
This rather general statement is in line with a more in depth
biochemical study (Wieland et al., 2005) showing that expres-
sion of the amino acids transporter SLC1A5 (specific for neutral
amino acids) is highly induced in the human monocyte cell line
MM6 upon infection by L. pneumophila. This study also shows
that functional SLC1A5 transporter is important for L. pneu-
mophila proliferation in these cells and preliminary evidence
suggests that SLC1A5 is translocated to the LCV membrane thus
supporting the uptake of cysteine, serine, and glutamine into
the LCV. These amino acids seem to be essential carbon sources
for growth of intracellular L. pneumophila (Price et al., 2011).
Interestingly, induction of the amino acid transporter SLC1A5 has
been also reported in THP-1 cells infected by the intracellularly
replicating Francisella tularensis (Barel et al., 2012).
In summary, solid experimental data on metabolic responses
of the primary host cells (i.e., macrophages in human infec-
tions and amoebae in natural environments) to L. pneumophila
are scarce. Clearly, in depth biochemical studies (especially using
humanmacrophages) are needed to support the interesting, albeit
mostly still preliminary findings, and to answer the important
question of how L. pneumophila modulates the metabolism in
its target cells. Some of the numerous Legionella effector proteins
might be interesting candidates.
CONCLUSIONS
Despite the rather limited knowledge that is currently available
concerning metabolic responses of mammalian cells to bac-
terial pathogens, some common and pathogen-specific motifs
are recognizable. As expected, most of the general observed
changes in host cell metabolism support cell protection and
include in particular the induced expression of iNOS, PHOX, and
IDO, leading to increased production of ROS, RNI, and tryp-
tophan degradation products, respectively. The also frequently
observed decreased expression of nucleoside transporter, isoci-
trate dehydrogenase, malic enzyme, and PYGLmay cause reduced
access to essential metabolic intermediates for the invading
pathogens. Another common theme seems to be the generation
of hypoxic conditions leading to HIF-1α stabilization with the
subsequent induction of HIF-1 dependent genes which comprise
also the genes involved in glucose uptake and GL. These com-
mon metabolic host responses (denoted as “core response”) are
mainly triggered by bacterial PAMPs, shared by pathogenic and
non-pathogenic bacteria.
However, bacterial pathogens may induce in addition specific
metabolic host responses which are probably in favor of these bac-
teria. As illustrated by the intracellular pathogens discussed above
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(most information on metabolic host responses comes from
intracellular bacterial pathogens), some evidence exists that spe-
cific virulence factors and effector proteins may trigger responses
that divert metabolic host reactions in support of the survival
and growth of the individual pathogen. However, there is still
little knowledge on the precise nature of these bacterial factors
and even less on the interacting host targets causing the specific
metabolic host changes.
The so far recognized specific host responses triggered by bac-
terial pathogens include: (a) induction of host cell enzymes which
dampens the production or action of ROS and RNI, e.g., cata-
lase and arginase, (b) further enhanced glucose uptake and GL
which stimulate the host cell’s anabolic activity (e.g., by increased
production of nucleotides and amino acids), thus providing addi-
tional metabolites to the intracellular pathogens, (c) switch to
enhanced glutaminolysis and citrate lyase reaction reinforcing
fatty acid/lipid biosynthesis, (d)modulations in lipidmetabolism,
including changes in the biosynthesis of steroid and eicosanoid
hormones that alter signaling pathways subsequently leading to
metabolic shifts. An overview on these host cell responses is also
given in Figure 5.
As we repeatedly mentioned, the majority of the specific host
responses are, however, only observed in in vivo infection models,
but not in the frequently used established cell lines which rep-
resent cancer cells or artificially transformed cells. Most of these
host cells have already experienced massive metabolic changes
whichmay be similar to those triggered by the bacterial pathogens
and hence may mask pathogen-induced host responses.
OUTLOOK
This review illustrates that we are still far away from an in-depth
understanding how the host (cell) metabolism is changed during
infection by bacterial pathogens and how these metabolic changes
affect the outcome of the infection. In the last decade espe-
cially cancer research has produced a wealth of new insights into
the metabolism of mammalian cells and its complex regulation
FIGURE 5 | Summary overview showing the major metabolic
pathways and reactions of a metabolically active mammalian host cell
(blue spheres and boxes) and the regulatory network with the major
regulators (green box) that control host cell metabolism. Blue arrows
indicate exchange of metabolites and intermediates of the different
metabolic functional units. Green arrows indicate control of these
functional units by specific regulators. The pink sphere indicates an
(intracellular) bacterial pathogen with surface components (red triangles),
T3SS or T4SS effector proteins and other secreted virulence factors (red
bars and circles) that might interact with metabolic targets of the host cell.
The red dashed arrows indicate already confirmed or probable interactions
(see text for details).
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(for recent reviews, see Smolková et al., 2011; Chen and Russo,
2012): (a) The involvement of certain protooncogenes and tumor
suppressors, e.g., c-Myc and p53, as important transcriptional
regulators of the genes encoding key enzymes for metabolic
pathways and of miRNAs controlling their synthesis is now well-
established (Cheung and Vousden, 2010; Dang, 2010; Gaglio
et al., 2011). (b) Multiple specific hormone and nutrient recep-
tors (“transceptors”) and signaling pathways have been shown to
be involved in the regulation and modulation of cell metabolism
and proliferation (Boulahbel et al., 2009; Dunlop and Tee, 2009;
Hardie, 2011; Mosca et al., 2011).
Yet, not only these complex regulatory networks are of
utmost importance for manipulating host cell metabolism, but
also modulations in the activity of many enzymes involved
in pathways of carbon-, nitrogen-, and energy metabolism.
These modulations are often performed by phosphorylation,
acetylation, or other post-translational reactions. In addition,
many metabolic enzymes exist in different isoforms, and
switches from one to another isoform may also alter metabolic
fluxes.
It is likely, but not yet experimentally proven, that bacte-
rial (especially intracellular) pathogens with their plethora of
PAMPs and pathogenicity factors acting as effectors of host
cell processes may influence the numerous regulatory host cell
devices and/or the activity of metabolic enzymes by direct
or indirect interaction. Indeed, some of the above described
metabolic changes observed in host cells upon infection by the
different bacterial pathogens could be readily explained by such
interactions.
In-depth investigations on the interactions of metabolic host
targets with components of the bacterial pathogens and the
impact of these interactions on host cell metabolism certainly
represent an exciting research area which may significantly
extend our understanding of bacterial pathogenesis. Classic high
throughput (“omics”) techniques will not suffice to solve these
challenging problems. The adaptation and further development
of new biochemical and physical techniques (in part described
in this review) which allow the detection of cellular metabolic
changes under in vivo conditions will be necessary for achieving
this great task.
And last but not least—as repeatedly mentioned—it will be
absolutely crucial to carry out these studies with appropriate
in vivomodels which make it possible to detect metabolic changes
triggered by the bacterial pathogens during latent, acute, or
chronic stages of infection.
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